OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Virtual screening and drug repositioning of FDA-approved drugs from the ZINC database to identify the potential hTERT inhibitors
Hasan Afzaal, Reem Altaf, Umair Ilyas, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
Hasan Afzaal, Reem Altaf, Umair Ilyas, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 7
Showing 7 citing articles:
Enhancement of cannabidiol oral bioavailability through the development of nanostructured lipid carriers: In vitro and in vivo evaluation studies
Iman Taha, Mahmoud A. ElSohly, Aly F. Mohamed, et al.
Drug Delivery and Translational Research (2024)
Open Access | Times Cited: 3
Iman Taha, Mahmoud A. ElSohly, Aly F. Mohamed, et al.
Drug Delivery and Translational Research (2024)
Open Access | Times Cited: 3
Transcriptomic Insight and Structural Integration: Repositioning FDA-Approved Methotrexate Derivative for Precision Therapy in Lung Cancer through Drug-Drug Similarity Analysis and Cavity-Guided Blind Docking
Harshal Tare, Vaishali Vaidya, Swati Fulmali, et al.
International Research Journal of Multidisciplinary Scope (2024) Vol. 05, Iss. 01, pp. 631-639
Open Access | Times Cited: 1
Harshal Tare, Vaishali Vaidya, Swati Fulmali, et al.
International Research Journal of Multidisciplinary Scope (2024) Vol. 05, Iss. 01, pp. 631-639
Open Access | Times Cited: 1
Pan-cancer analysis reveals the prognostic and immunomodulatory potential of super-enhancer-induced ANGPT2 and experimental validation in colorectal cancer
Shouwu Guo, Yanan Yu, Yulan Bu, et al.
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 1
Shouwu Guo, Yanan Yu, Yulan Bu, et al.
Clinical & Translational Oncology (2024)
Closed Access | Times Cited: 1
Computational analysis and drug repositioning: Targeting the TDP-43 RRM using FDA-approved drugs
Siran Zhang, Longjiang Wu, Xiaoying Zhang, et al.
(2024)
Open Access | Times Cited: 1
Siran Zhang, Longjiang Wu, Xiaoying Zhang, et al.
(2024)
Open Access | Times Cited: 1
Identification and validation of differentially expressed genes for targeted therapy in NSCLC using integrated bioinformatics analysis
Reem Altaf, Umair Ilyas, Anmei Ma, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
Reem Altaf, Umair Ilyas, Anmei Ma, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 2
In-silico studies of isolated biological active fractions of Vachellia nilotica leaves extract against MG 63 cell lines and biological applications
Neha Verma, Mohini Singh, Shilpa Kumari, et al.
Biocatalysis and Agricultural Biotechnology (2024) Vol. 60, pp. 103276-103276
Closed Access
Neha Verma, Mohini Singh, Shilpa Kumari, et al.
Biocatalysis and Agricultural Biotechnology (2024) Vol. 60, pp. 103276-103276
Closed Access
Identification of Azelastine and Carvedilol as Cholinesterase Inhibitors via Structure‐Based Virtual Screening of FDA‐approved Drugs
Mohit Sharma, Shikha Thakur, Hemant R. Jadhav, et al.
ChemistrySelect (2023) Vol. 8, Iss. 28
Closed Access | Times Cited: 1
Mohit Sharma, Shikha Thakur, Hemant R. Jadhav, et al.
ChemistrySelect (2023) Vol. 8, Iss. 28
Closed Access | Times Cited: 1
